HumanexaHumanexaHumanexa
WelcomeSignalsCompaniesScenario AnalysisRegulatoryStrategy
InsightsNewslettersReportsBriefings
Pricing
WorkspaceTeamWatchlistsCollectionsSettings

Free

Intelligence Active

FDA source evidence

ANDA215411

FDA application evidence

ANDA215411

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Application summary

Application number
ANDA215411
Sponsor
INVENTIA HEALTHCARE LIMITED
Product / brand name
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
Active ingredients
SITAGLIPTIN, METFORMIN HYDROCHLORIDE
Submission type
ORIG
Submission status
TA
Submission date
20260507
Review priority
STANDARD
Dosage form
TABLET
Marketing status
None (Tentative Approval)
View raw openFDA evidence
PrivacyTermsRefund PolicyDisclaimerContact

© 2026 Humanexa. Intelligence for research workflows — not medical, legal, regulatory filing, or investment advice.